Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
Typical durations range from hours to days
In the last two decades, compounding found new life with the boom in testosterone for men, hormone-replacement therapy for women, and, more recently, GLP-1 weight-loss drugs
B12 injections are not something to start and then continue indefinitely without review
Low-dose naltrexone treatment for patients exploring appetite management
As B12 levels return to normal, patients often experience improvements in skin hydration, regeneration, and overall appearance